Chipmaker Analog Devices (Nasdaq: ADI) Q2 earnings and revenue beat analysts expectations. However, the stock fell about 2% in the early hours of pre-market trading due to weak Q3 outlook and recovered later.
Adjusted earnings per share declined 9% year-over-year to $1.36 and revenue dropped 2% to $1.53 billion for the second quarter ended May 4, 2019. Analysts had projected the company to post earnings of $1.30 per share on revenue of $1.5 billion.
For the third quarter of 2019, Analog Devices expects GAAP EPS to be $0.86, +/- $0.07, and adjusted EPS to be $1.22, +/- $0.07. Revenue for the third quarter is forecasted to be $1.45 billion, +/- $50 million.
Analog Devices stated that this guidance considers the estimated impact on ADI from the U.S. Government’s recently announced export restrictions on Huawei Technologies. As of now, Analog Devices had ceased shipments of products to Huawei, and is reviewing the ability to resume shipments under the recently announced temporary general license.
Also read: Texas Instruments Q1 earnings results
“We continue to execute exceptionally well in an uncertain environment. Revenue and EPS came in at the high-end of our guidance, led by strong growth in our communication applications across multiple markets,” said CEO Vincent Roche.
Shares of Analog Devices, which closed up 2.44% at $99.88 on Tuesday, have gained 16% so far this year and 5% in the past 12 months.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
Comments